Distribution of azithromycin into brain tissue, cerebrospinal fluid, and aqueous humor of the eye
- 1 March 1996
- journal article
- clinical trial
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 40 (3) , 825-826
- https://doi.org/10.1128/aac.40.3.825
Abstract
To measure the concentrations of azithromycin in the central nervous system, 20 patients with brain tumors (group I) received a single 500-mg oral dose of azithromycin either 24, 48, 72, or 96 h prior to the tumor removal operation and 10 patients with cataracts undergoing surgery (group II) and 7 patients scheduled to undergo lumbar puncture (group III) received the same dose of azithromycin 24 h prior to the operation or procedure. Serum from all patients, brain tissue from group I, aqueous humor from group II, and cerebrospinal fluid from group III were assayed for azithromycin concentration. The mean concentrations of azithromycin in brain tissue 24, 48, 72, and 96 h after administration were 2.63 +/- 2.58, 3.64 +/- 3.81, 0.74 +/- 0.37, and 0.41 micrograms/g, respectively. In contrast, the concentrations of azithromycin in cerebrospinal fluid and aqueous humor of the eye were very low or undetectable. Therefore, these data show that azithromycin appears to be widely distributed into brain tissue but not into cerebrospinal fluid or aqueous humor of the eye.Keywords
This publication has 8 references indexed in Scilit:
- AzithromycinDrugs, 1992
- The pharmacokinetics of azithromycin and their clinical significanceEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Concentrations of azithromycin in human tonsillar tissueEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Spectrum of activity of azithromycinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- In vivo activity of the macrolide antibiotics azithromycin, roxithromycin and spiramycin againstToxoplasma gondiiEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Activity in vitro against Toxoplasma gondii of azithromycin and clarithromycin alone and with pyrimethamineJournal of Antimicrobial Chemotherapy, 1990
- In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infectionAntimicrobial Agents and Chemotherapy, 1989
- Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondiiAntimicrobial Agents and Chemotherapy, 1988